NEWTOWN, Pa., Dec. 16, 2024 (GLOBE NEWSWIRE) -- Forian Inc. (Nasdaq: FORA), a leading provider of data science driven information and analytics solutions to the life science, healthcare and financial services industries, today announced a partnership with Databricks, the data and AI company, to deliver access to its Chartis™ product, which maps physician and organization affiliations, through Databricks Marketplace . This... Read More

NEWTOWN, Pa., Nov. 13, 2024 (GLOBE NEWSWIRE) -- NEWTOWN, Pa. Forian Inc. (Nasdaq: FORA), a leading provider of data science driven information and analytics solutions to the life science, healthcare and financial services industries, today announced results for the quarter ended September 30, 2024. “While this quarter’s revenue remained steady, our team’s commitment to driving long-term value has resulted in progress in our... Read More

NEWTOWN, Pa., Nov. 08, 2024 (GLOBE NEWSWIRE) -- Forian Inc. (Nasdaq: FORA) announces that Max Wygod, Chief Executive Officer and Executive Chairman, and Mike Vesey, Chief Financial Officer, will attend ROTH MKM’s 13th annual Technology Event, which will be held on November 19th – 20th, 2024, at the Hard Rock Hotel in New York City. This year’s event will consist of 1-on-1 / small group meetings with over 70 innovative growth... Read More

NEWTOWN, Pa., Nov. 05, 2024 (GLOBE NEWSWIRE) -- Forian Inc. (Nasdaq: FORA), a provider of data science driven information and analytics solutions to the healthcare and life sciences industries, will announce its third quarter 2024 financial results on Wednesday, November 13, 2024, after the close of the market. The Company will host a conference call and webcast at 4:30 p.m. (ET) on November 13, 2024 to discuss the results.... Read More

NEWTOWN, PA, Nov. 01, 2024 (GLOBE NEWSWIRE) -- Forian Inc. (Nasdaq: FORA), a provider of data science driven information and analytics solutions to the healthcare and life sciences industries, today announced it has acquired Kyber Data Science LLC (“Kyber”), a trusted provider of advanced healthcare data analytics and machine learning solutions to the financial services industry, from TD Cowen. This strategic acquisition... Read More

NEWTOWN, PA, Aug. 14, 2024 (GLOBE NEWSWIRE) -- Forian Inc. (Nasdaq: FORA) , a provider of data science driven information and analytics solutions to the healthcare and life sciences industries, today announced results for the quarter ended June 30, 2024. “We continued to invest in our information assets in the second quarter to further differentiate our offerings and the insights they power for our customers. We remain... Read More

NEWTOWN, PA , Aug. 02, 2024 (GLOBE NEWSWIRE) -- Forian Inc. (Nasdaq: FORA), a provider of data science driven information and analytics solutions to the healthcare and life sciences industries, will announce its second quarter 2024 financial results on Wednesday, August 14, 2024, after the close of the market. The Company will host a conference call and webcast at 4:30 p.m. (ET) on August 14, 2024 to discuss the results. To... Read More

Media and Investor Contact: forian.com/investors ir@forian.com 267-225-6263 NEWTOWN, PA, April 14, 2024 (GLOBE NEWSWIRE) -- via NewMediaWire -- Forian Inc. (Nasdaq:FORA), a provider of data science driven information and analytics solutions to the healthcare and life sciences industries, is deeply saddened to announce the passing of its director, Martin J. Wygod (Marty), on Friday at age 84. Marty was a healthcare... Read More

Full Year 2023 Revenue Grew 25% Full Year 2023 Adjusted EBITDA of $2.3MM NEWTOWN, PA, March 28, 2024 (GLOBE NEWSWIRE) -- via NewMediaWire -- Forian Inc. (Nasdaq: FORA) , a provider of data science driven information and analytics solutions to the healthcare and life sciences industries, today announced results for the quarter and year ended December 31, 2023. “Forian finished the year by executing against our quarterly plan... Read More

NEWTOWN, PA, March 08, 2024 (GLOBE NEWSWIRE) -- via NewMediaWire -- Forian Inc. (Nasdaq: FORA), a provider of data science driven information and analytics solutions to the healthcare and life sciences industries, will announce its fourth quarter and full year 2023 financial results on Thursday, March 28, 2024, after the close of the market. The Company will host a conference call and webcast at 4:30 p.m. (ET) on March 28,... Read More

Third quarter revenue grew 24% year-over-year Forian data factory expanded to drive improved insights NEWTOWN, PA, Nov. 09, 2023 (GLOBE NEWSWIRE) -- via NewMediaWire – Forian Inc. (Nasdaq: FORA) , a provider of data science driven information and analytics solutions to the healthcare and life sciences industries, today announced results for the quarter ended September 30, 2023. “Our strong financial quarter highlighted by an... Read More

NEWTOWN, PA, Nov. 01, 2023 (GLOBE NEWSWIRE) -- via NewMediaWire – Forian Inc. (Nasdaq:FORA), a provider of data science driven information and analytics solutions to the healthcare and life sciences industries, will announce its third quarter 2023 financial results on Thursday, November 9, 2023, after the close of the market. The Company will host a conference call and webcast at 5:00 p.m. (ET) on November 9, 2023, to... Read More

NEWTOWN, PA, Oct. 31, 2023 (GLOBE NEWSWIRE) -- via NewMediaWire – Forian Inc. (Nasdaq:FORA) announces that Max Wygod, Chief Executive Officer and Executive Chairman, and Mike Vesey, Chief Financial Officer, will attend ROTH MKM’s 12th annual Technology Event, which will be held on November 15, 2023, at the Yale Club in New York City. This event will provide investors the opportunity to meet with executive management from... Read More

NEWTOWN, PA, Oct. 03, 2023 (GLOBE NEWSWIRE) -- via NewMediaWire – Forian Inc. (Nasdaq: FORA) , a provider of data science driven information and analytics solutions to the healthcare and life sciences industries, today announced that it has repurchased an aggregate of 1,604,676 shares of Forian common stock in a privately negotiated transaction at redemption price of $2.15 per share for an aggregate purchase price of... Read More

Second quarter revenue grew 36% year-over-year NEWTOWN, PA, Aug. 10, 2023 (GLOBE NEWSWIRE) -- via NewMediaWire – Forian Inc. (N asdaq : FORA) , a provider of data science driven information and analytics solutions to the healthcare and life sciences industries, today announced results for the quarter ended June 30, 2023. “Forian’s commitment to delivering value to our customers and shareholders in a more challenging fiscal... Read More

\NEWTOWN, PA, July 26, 2023 (GLOBE NEWSWIRE) -- via NewMediaWire -- Forian Inc. (Nasdaq: FORA), a provider of data science driven information and analytics solutions to the healthcare and life sciences industries, will announce its second quarter 2023 financial results on Thursday, August 10, 2023, after the close of the market. The Company will host a conference call and webcast at 4:30 p.m. (ET) on August 10, 2023 to... Read More

First quarter revenue grew 38% year over year NEWTOWN, PA, May 12, 2023 (GLOBE NEWSWIRE) -- via NewMediaWire – Forian Inc. (N asdaq : FORA) , a provider of data science driven information and analytics solutions to the healthcare and life sciences industries, today announced results for the quarter ended March 31, 2023. “As we continue our transition into a pure-play healthcare information company, Forian delivered another... Read More

NEWTOWN, PA, May 01, 2023 (GLOBE NEWSWIRE) -- via NewMediaWire -- Forian Inc. (Nasdaq:FORA), a provider of data science driven information and analytics solutions to the healthcare and life sciences industries, will announce its first quarter 2023 financial results on Friday, May 12, 2023, after the close of the market. The Company will host a conference call and webcast at 4:30 p.m. (ET) on May 12, 2023 to discuss the... Read More

Fourth quarter revenue grew 37% year-over-year Forian exits cannabis industry with sale of BioTrack for $30 million NEWTOWN, PA, March 27, 2023 (GLOBE NEWSWIRE) -- via NewMediaWire – Forian Inc. (Nasdaq: FORA), a provider of data science driven information and analytics solutions to the healthcare and life sciences industries, today announced results for the quarter and year ended December 31, 2022. “I am proud of the team’s... Read More

NEWTOWN, PA, March 14, 2023 (GLOBE NEWSWIRE) -- via NewMediaWire – Forian Inc . (Nasdaq: FORA), a provider of data science driven information and analytics solutions to the healthcare and life sciences industries, will announce its fourth quarter and full year 2022 financial results on Monday, March 27, 2023, after the close of the market. The Company will host a conference call and webcast at 4:30 p.m. (ET) on March 27,... Read More

NEWTOWN, PA and DEERFIELD BEACH, FL, Feb. 13, 2023 (GLOBE NEWSWIRE) -- via NewMediaWire -- Forian Inc. (Nasdaq: FORA), a provider of technology, analytics and data science driven solutions, today announced the sale of Forian’s cannabis software subsidiary, Bio-Tech Medical Software, Inc. (d/b/a BioTrack), to Alleaves, Inc., a provider of ERP software solutions to the cannabis industry, effective February 10, 2023, for a... Read More

NEWTOWN, PA, Dec. 20, 2022 (GLOBE NEWSWIRE) -- via NewMediaWire – Forian Inc. (NASDAQ: FORA), a provider of technology, analytics and data science driven solutions for the healthcare and cannabis industries, today announced that New York has selected BioTrack as the track and trace system for the New York Office of Cannabis Management’s Cannabis Seed to Sale Tracking System. The BioTrack software, commonly referred to as... Read More

Revenue grows to $7.2 million On track to exceed 2022 revenue guidance Newtown, PA, Nov. 14, 2022 (GLOBE NEWSWIRE) -- via NewMediaWire -- Forian Inc. (Nasdaq: FORA) , a provider of technology, analytics and data science driven solutions for the healthcare and cannabis industries, today announced results for the quarter ended September 30, 2022. “Forian’s third quarter results demonstrate our business model’s ability to... Read More

Forian Inc. (Nasdaq:FORA), a provider of software, data, and analytics-enabled services for the healthcare and cannabis industries, will announce its financial results for the three months ended September 30, 2022 on Monday, November 14, 2022, after the close of the market. The Company will host a conference call and webcast at 4:30 p.m. (ET) on November 14, 2022, to discuss the results. To register for the conference call,... Read More

Revenue grows to $6.5 million Reaffirms 2022 revenue guidance of $25.5 to $27.0 million Forian Inc. (Nasdaq: FORA) , a provider of technology, analytics and data science driven solutions for the healthcare and cannabis industries, today announced results for the quarter ended June 30, 2022. “Forian delivered strong financial results in the second quarter, reflecting growing demand across our offerings,” said Max Wygod,... Read More

Forian Inc. (Nasdaq:FORA), a provider of software, data, and analytics-enabled services for the healthcare and cannabis industries, will announce its financial results for the three months ended June 30, 2022 on Thursday, August 11, 2022 after the close of the market. The Company will host a conference call and webcast at 4:30 p.m. (ET) on August 11, 2022 to discuss the results. To register for the conference call, click... Read More

Revenue grows to $6.4 million Reaffirms 2022 revenue guidance of $25.5 to $27.0 million Forian Inc. (Nasdaq: FORA) , a provider of technology, analytics and data science driven solutions for the healthcare and cannabis industries, today announced results for the quarter ended March 31, 2022. “The first quarter performance was a strong start to 2022," said Max Wygod, Forian Executive Chairman. "We are successfully executing... Read More

Forian Inc. (Nasdaq:FORA), a provider of software, data, and analytics-enabled services for the healthcare and cannabis industries, will announce its financial results for the three months ended March 31, 2022 on Thursday, May 12, 2022 after the close of the market. The Company will host a conference call and webcast at 4:30 p.m. (ET) on May 12, 2022 to discuss the results. To access the conference call, from the US dial... Read More

Forian Inc. (Nasdaq:FORA), a leading provider of technology, predictive analytics and data science-driven software solutions for the healthcare and cannabis industries, today announced its participation in the Benzinga Cannabis Capital Conference to be held April 20-21, 2022 at the Fontainebleau Miami Beach hotel located in Miami Beach, Florida. Andrew Douglas, Forian Chief Data and Analytics Officer, will present on the... Read More

Forian Inc. (Nasdaq: FORA), a provider of technology, analytics and data science driven solutions for the healthcare and cannabis industries, announced that its subsidiary, Bio-Tech Medical Software, Inc. (d/b/a BioTrack), successfully completed the planned April 1, 2022 launch of its New Mexico state traceability system for adult use cannabis sales. This latest state partnership demonstrates the continued expansion of... Read More

FY21 revenue of $16.9 million met high end of revenue outlook Company provides outlook for continued growth in FY22 Forian Inc. (NASDAQ: FORA) , a provider of technology, analytics and data science driven solutions for the healthcare and cannabis industries, today announced results for the quarter and year ended December 31, 2021. “We have achieved many milestones in the last year,” said Max Wygod, Forian Executive Chairman.... Read More

Forian Inc. (Nasdaq:FORA), a leading provider of technology, predictive analytics and data science driven software solutions for the healthcare and cannabis industries, has been invited to attend the 34th Annual Roth Conference to be held March 13-15, 2022, at The Ritz Carlton, Laguna Niguel located in Dana Point, California. Forian Executive Chairman, Max Wygod, will present at the Roth Conference on the New Issue Track on... Read More

Forian Inc. (Nasdaq:FORA), a provider of software, data, and analytics-enabled services for the healthcare and cannabis industries, will announce its financial results for the fourth quarter and year ending on December 31, 2021 on Thursday, March 24, 2022 after the close of the market. The Company will host a conference call and webcast at 4:30 p.m. (ET) on March 24, 2022 to discuss the results. To access the conference... Read More

Third Quarter Revenue of $5.0 Million, Up $4.8 Million Year-Over-Year, Pro Forma Year-Over-Year Growth of 62% Forian Inc. (NASDAQ: FORA) , a provider of technology, analytics and data science driven solutions for the healthcare and cannabis industries, today announced results for the fiscal quarter ended September 30, 2021. “I am proud of the Forian team’s work to achieve our organic financial growth goals as we invest to... Read More

Forian Inc. (Nasdaq:FORA) , a provider of software, data, and analytics-enabled services for the healthcare and cannabis industries, will announce its financial results for the three months ended September 30, 2021 on Thursday, November 11, 2021 after the close of the market. The Company will host a conference call at 4:30 p.m. (ET) on November 11, 2021 to discuss the results. To access the conference call, from the US dial... Read More

Forian Inc. (NASDAQ: FORA), a provider of technology, analytics and data science driven solutions for the healthcare and cannabis industries, today announced the following: Convertible Notes Offering The Company has entered into a convertible note purchase agreement (the "Note Purchase Agreement") with a select group of... Read More

Mind Medicine (MindMed) Inc. (NASDAQ: MNMD), (NEO: MMED), (DE: MMQ) (the "Company"), a leading biotech company developing psychedelic-inspired therapies, has agreed to work with Forian Inc. (NASDAQ: FORA), a leading provider of evidence-based support for more comprehensive clinical and commercial decision-making. MindMed and Forian will collaborate to develop best practices for using real-world evidence ("RWE") information... Read More

Forian Inc. (NASDAQ: FORA), a provider of technology, analytics and data science driven solutions for the healthcare and cannabis industries, today announced results for the fiscal quarter ended June 30, 2021 . "As an early stage growth company, we were proud to be added to the Russell 3000 Index," said Max Wygod, Executive Chairman of Forian. "We believe the momentum we established in the quarter positions Forian to... Read More

Forian Inc. (Nasdaq:FORA) , a provider of software and technology-enabled services for the healthcare and cannabis industries, will announce its financial results for the three months ended June 30, 2021 on Thursday, August 12, 2021 after the close of the market. The Company will host a conference call at 4:30 p.m. (ET) on... Read More

Forian Inc. is set to join the broad-market Russell 3000 ® Index at the conclusion of the 2021 Russell indexes annual reconstitution, effective after the US market opens on June 28, 2021 , according to a preliminary list of additions posted June 4, 2021 . Annual Russell indexes reconstitution captures the 4,000 largest US... Read More

Forian Inc. (NASDAQ: FORA) , a provider of technology, analytics and data science driven solutions for the healthcare and cannabis industries, today announced results for its fiscal first quarter ended March 31, 2021 . "This quarter was transformational for Forian. We completed a strategic business combination with Helix... Read More

Forian Inc. (Nasdaq:FORA) , a provider of software and technology-enabled services for the healthcare and cannabis industries, will announce its financial results for the three months ended March 31, 2021 before the market opens on Monday, May 17, 2021 . The Company will host a conference call at 8:30 a.m. (ET) on May 17, 2021... Read More

Forian Inc. (Nasdaq:FORA) , a provider of software and technology-enabled services for the healthcare and cannabis industries, announced today that it has entered into a securities purchase agreement with a select group of institutional and accredited investors to raise gross proceeds of $12,000,000 resulting from the sale of... Read More

Forian Inc. announced that it has completed the combination of Helix Technologies, Inc. (OTCQB:HLIX) and Medical Outcomes Research Analytics, LLC. The combination empowers Forian to provide a unique suite of SaaS solutions, data management capabilities and proprietary data and analytics to optimize and measure operational, clinical and financial performance for customers within the traditional and emerging life sciences,... Read More